Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

November 01, 1988; Volume 34,Issue 5
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

B

  1. Bero, L A

    1. You have access
      Identification of endogenous opioid receptor components in rat brain using a monoclonal antibody.
      L A Bero, S Roy and N M Lee
      Molecular Pharmacology November 1988, 34 (5) 614-620;
  2. Bradfield, C A

    1. You have access
      A competitive binding assay for 2,3,7,8-tetrachlorodibenzo-p-dioxin and related ligands of the Ah receptor.
      C A Bradfield and A Poland
      Molecular Pharmacology November 1988, 34 (5) 682-688;
  3. Burchell, B

    1. You have access
      Examination of the substrate specificity of cloned rat kidney phenol UDP-glucuronyltransferase expressed in COS-7 cells.
      M R Jackson, S Fournel-Gigleux, D Harding and B Burchell
      Molecular Pharmacology November 1988, 34 (5) 638-642;

D

  1. Daly, J W

    1. You have access
      Local anesthetics: comparison of effects on batrachotoxin-elicited sodium flux and phosphoinositide breakdown in guinea pig cerebral cortical synaptoneurosomes.
      Y Nishizawa, F Gusovsky and J W Daly
      Molecular Pharmacology November 1988, 34 (5) 707-713;
  2. Devane, W A

    1. You have access
      Determination and characterization of a cannabinoid receptor in rat brain.
      W A Devane, F A Dysarz, M R Johnson, L S Melvin and A C Howlett
      Molecular Pharmacology November 1988, 34 (5) 605-613;
  3. Ducote, J

    1. You have access
      Methyl mercury stimulates chain elongation by purified HeLa RNA polymerase II.
      G D Frenkel and J Ducote
      Molecular Pharmacology November 1988, 34 (5) 702-706;
  4. Duff, H J

    1. You have access
      Determinants of stereospecific binding of type I antiarrhythmic drugs to cardiac sodium channels.
      R J Hill, H J Duff and R S Sheldon
      Molecular Pharmacology November 1988, 34 (5) 659-663;
  5. Dysarz, F A

    1. You have access
      Determination and characterization of a cannabinoid receptor in rat brain.
      W A Devane, F A Dysarz, M R Johnson, L S Melvin and A C Howlett
      Molecular Pharmacology November 1988, 34 (5) 605-613;

F

  1. Fournel-Gigleux, S

    1. You have access
      Examination of the substrate specificity of cloned rat kidney phenol UDP-glucuronyltransferase expressed in COS-7 cells.
      M R Jackson, S Fournel-Gigleux, D Harding and B Burchell
      Molecular Pharmacology November 1988, 34 (5) 638-642;
  2. Frenkel, G D

    1. You have access
      Methyl mercury stimulates chain elongation by purified HeLa RNA polymerase II.
      G D Frenkel and J Ducote
      Molecular Pharmacology November 1988, 34 (5) 702-706;

G

  1. Ganey, P E

    1. You have access
      Oxygen-dependent hepatotoxicity due to doxorubicin: role of reducing equivalent supply in perfused rat liver.
      P E Ganey, F C Kauffman and R G Thurman
      Molecular Pharmacology November 1988, 34 (5) 695-701;
  2. Gusovsky, F

    1. You have access
      Local anesthetics: comparison of effects on batrachotoxin-elicited sodium flux and phosphoinositide breakdown in guinea pig cerebral cortical synaptoneurosomes.
      Y Nishizawa, F Gusovsky and J W Daly
      Molecular Pharmacology November 1988, 34 (5) 707-713;

H

  1. Harding, D

    1. You have access
      Examination of the substrate specificity of cloned rat kidney phenol UDP-glucuronyltransferase expressed in COS-7 cells.
      M R Jackson, S Fournel-Gigleux, D Harding and B Burchell
      Molecular Pharmacology November 1988, 34 (5) 638-642;
  2. Hawrot, E

    1. You have access
      Distribution of alpha-bungarotoxin binding sites over residues 173-204 of the alpha subunit of the acetylcholine receptor.
      P T Wilson, E Hawrot and T L Lentz
      Molecular Pharmacology November 1988, 34 (5) 643-650;
  3. Hill, R J

    1. You have access
      Determinants of stereospecific binding of type I antiarrhythmic drugs to cardiac sodium channels.
      R J Hill, H J Duff and R S Sheldon
      Molecular Pharmacology November 1988, 34 (5) 659-663;
  4. Hirning, L D

    1. You have access
      The role of caffeine-sensitive calcium stores in the regulation of the intracellular free calcium concentration in rat sympathetic neurons in vitro.
      S A Thayer, L D Hirning and R J Miller
      Molecular Pharmacology November 1988, 34 (5) 664-673;
  5. Howlett, A C

    1. You have access
      Determination and characterization of a cannabinoid receptor in rat brain.
      W A Devane, F A Dysarz, M R Johnson, L S Melvin and A C Howlett
      Molecular Pharmacology November 1988, 34 (5) 605-613;
  6. Hulla, J E

    1. You have access
      On the substrate specificity of cytochrome P450IIIA1.
      M J Namkung, H L Yang, J E Hulla and M R Juchau
      Molecular Pharmacology November 1988, 34 (5) 628-637;

J

  1. Jackson, M R

    1. You have access
      Examination of the substrate specificity of cloned rat kidney phenol UDP-glucuronyltransferase expressed in COS-7 cells.
      M R Jackson, S Fournel-Gigleux, D Harding and B Burchell
      Molecular Pharmacology November 1988, 34 (5) 638-642;
  2. Johnson, M R

    1. You have access
      Determination and characterization of a cannabinoid receptor in rat brain.
      W A Devane, F A Dysarz, M R Johnson, L S Melvin and A C Howlett
      Molecular Pharmacology November 1988, 34 (5) 605-613;
  3. Jones, T W

    1. You have access
      Immunohistochemical localization of glutamine transaminase K, a rat kidney cysteine conjugate beta-lyase, and the relationship to the segment specificity of cysteine conjugate nephrotoxicity.
      T W Jones, C Qin, V H Schaeffer and J L Stevens
      Molecular Pharmacology November 1988, 34 (5) 621-627;
  4. Juchau, M R

    1. You have access
      On the substrate specificity of cytochrome P450IIIA1.
      M J Namkung, H L Yang, J E Hulla and M R Juchau
      Molecular Pharmacology November 1988, 34 (5) 628-637;

K

  1. Kauffman, F C

    1. You have access
      Oxygen-dependent hepatotoxicity due to doxorubicin: role of reducing equivalent supply in perfused rat liver.
      P E Ganey, F C Kauffman and R G Thurman
      Molecular Pharmacology November 1988, 34 (5) 695-701;
  2. Kushner, L

    1. You have access
      Characterization of opioid, sigma, and phencyclidine receptors in the neuroblastoma-brain hybrid cell line NCB-20.
      L Kushner, S R Zukin and R S Zukin
      Molecular Pharmacology November 1988, 34 (5) 689-694;

L

  1. Lee, N M

    1. You have access
      Identification of endogenous opioid receptor components in rat brain using a monoclonal antibody.
      L A Bero, S Roy and N M Lee
      Molecular Pharmacology November 1988, 34 (5) 614-620;
  2. Lentz, T L

    1. You have access
      Distribution of alpha-bungarotoxin binding sites over residues 173-204 of the alpha subunit of the acetylcholine receptor.
      P T Wilson, E Hawrot and T L Lentz
      Molecular Pharmacology November 1988, 34 (5) 643-650;

M

  1. McGirr, L G

    1. You have access
      The metabolism of N-acetyl-3,5-dimethyl-p-benzoquinone imine in isolated hepatocytes involves N-deacetylation.
      L Rossi, L G McGirr, J Silva and P J O'Brien
      Molecular Pharmacology November 1988, 34 (5) 674-681;
  2. Melvin, L S

    1. You have access
      Determination and characterization of a cannabinoid receptor in rat brain.
      W A Devane, F A Dysarz, M R Johnson, L S Melvin and A C Howlett
      Molecular Pharmacology November 1988, 34 (5) 605-613;
  3. Miller, R J

    1. You have access
      The role of caffeine-sensitive calcium stores in the regulation of the intracellular free calcium concentration in rat sympathetic neurons in vitro.
      S A Thayer, L D Hirning and R J Miller
      Molecular Pharmacology November 1988, 34 (5) 664-673;

N

  1. Namkung, M J

    1. You have access
      On the substrate specificity of cytochrome P450IIIA1.
      M J Namkung, H L Yang, J E Hulla and M R Juchau
      Molecular Pharmacology November 1988, 34 (5) 628-637;
  2. Nishizawa, Y

    1. You have access
      Local anesthetics: comparison of effects on batrachotoxin-elicited sodium flux and phosphoinositide breakdown in guinea pig cerebral cortical synaptoneurosomes.
      Y Nishizawa, F Gusovsky and J W Daly
      Molecular Pharmacology November 1988, 34 (5) 707-713;

O

  1. O'Brien, P J

    1. You have access
      The metabolism of N-acetyl-3,5-dimethyl-p-benzoquinone imine in isolated hepatocytes involves N-deacetylation.
      L Rossi, L G McGirr, J Silva and P J O'Brien
      Molecular Pharmacology November 1988, 34 (5) 674-681;

P

  1. Poland, A

    1. You have access
      A competitive binding assay for 2,3,7,8-tetrachlorodibenzo-p-dioxin and related ligands of the Ah receptor.
      C A Bradfield and A Poland
      Molecular Pharmacology November 1988, 34 (5) 682-688;
  2. Presky, D H

    1. You have access
      Iodination of [Tyr11]somatostatin yields a super high affinity ligand for somatostatin receptors in GH4C1 pituitary cells.
      D H Presky and A Schonbrunn
      Molecular Pharmacology November 1988, 34 (5) 651-658;

Q

  1. Qin, C

    1. You have access
      Immunohistochemical localization of glutamine transaminase K, a rat kidney cysteine conjugate beta-lyase, and the relationship to the segment specificity of cysteine conjugate nephrotoxicity.
      T W Jones, C Qin, V H Schaeffer and J L Stevens
      Molecular Pharmacology November 1988, 34 (5) 621-627;

R

  1. Rossi, L

    1. You have access
      The metabolism of N-acetyl-3,5-dimethyl-p-benzoquinone imine in isolated hepatocytes involves N-deacetylation.
      L Rossi, L G McGirr, J Silva and P J O'Brien
      Molecular Pharmacology November 1988, 34 (5) 674-681;
  2. Roy, S

    1. You have access
      Identification of endogenous opioid receptor components in rat brain using a monoclonal antibody.
      L A Bero, S Roy and N M Lee
      Molecular Pharmacology November 1988, 34 (5) 614-620;

S

  1. Schaeffer, V H

    1. You have access
      Immunohistochemical localization of glutamine transaminase K, a rat kidney cysteine conjugate beta-lyase, and the relationship to the segment specificity of cysteine conjugate nephrotoxicity.
      T W Jones, C Qin, V H Schaeffer and J L Stevens
      Molecular Pharmacology November 1988, 34 (5) 621-627;
  2. Schonbrunn, A

    1. You have access
      Iodination of [Tyr11]somatostatin yields a super high affinity ligand for somatostatin receptors in GH4C1 pituitary cells.
      D H Presky and A Schonbrunn
      Molecular Pharmacology November 1988, 34 (5) 651-658;
  3. Sheldon, R S

    1. You have access
      Determinants of stereospecific binding of type I antiarrhythmic drugs to cardiac sodium channels.
      R J Hill, H J Duff and R S Sheldon
      Molecular Pharmacology November 1988, 34 (5) 659-663;
  4. Silva, J

    1. You have access
      The metabolism of N-acetyl-3,5-dimethyl-p-benzoquinone imine in isolated hepatocytes involves N-deacetylation.
      L Rossi, L G McGirr, J Silva and P J O'Brien
      Molecular Pharmacology November 1988, 34 (5) 674-681;
  5. Stevens, J L

    1. You have access
      Immunohistochemical localization of glutamine transaminase K, a rat kidney cysteine conjugate beta-lyase, and the relationship to the segment specificity of cysteine conjugate nephrotoxicity.
      T W Jones, C Qin, V H Schaeffer and J L Stevens
      Molecular Pharmacology November 1988, 34 (5) 621-627;

T

  1. Thayer, S A

    1. You have access
      The role of caffeine-sensitive calcium stores in the regulation of the intracellular free calcium concentration in rat sympathetic neurons in vitro.
      S A Thayer, L D Hirning and R J Miller
      Molecular Pharmacology November 1988, 34 (5) 664-673;
  2. Thurman, R G

    1. You have access
      Oxygen-dependent hepatotoxicity due to doxorubicin: role of reducing equivalent supply in perfused rat liver.
      P E Ganey, F C Kauffman and R G Thurman
      Molecular Pharmacology November 1988, 34 (5) 695-701;

W

  1. Wilson, P T

    1. You have access
      Distribution of alpha-bungarotoxin binding sites over residues 173-204 of the alpha subunit of the acetylcholine receptor.
      P T Wilson, E Hawrot and T L Lentz
      Molecular Pharmacology November 1988, 34 (5) 643-650;

Y

  1. Yang, H L

    1. You have access
      On the substrate specificity of cytochrome P450IIIA1.
      M J Namkung, H L Yang, J E Hulla and M R Juchau
      Molecular Pharmacology November 1988, 34 (5) 628-637;

Z

  1. Zukin, R S

    1. You have access
      Characterization of opioid, sigma, and phencyclidine receptors in the neuroblastoma-brain hybrid cell line NCB-20.
      L Kushner, S R Zukin and R S Zukin
      Molecular Pharmacology November 1988, 34 (5) 689-694;
  2. Zukin, S R

    1. You have access
      Characterization of opioid, sigma, and phencyclidine receptors in the neuroblastoma-brain hybrid cell line NCB-20.
      L Kushner, S R Zukin and R S Zukin
      Molecular Pharmacology November 1988, 34 (5) 689-694;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 34, Issue 5
1 Nov 1988
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics